Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “GVHD - Graft-Versus-Host Disease”

1,058 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,058 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT07193420
What this trial is testing

Reduced Post-transplant Cyclophosphamide Dose in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation for Hematological Malignancies

Who this might be right for
GVHD - Graft-Versus-Host DiseaseHSCTHaploidentical Stem Cell Transplantation
Assistance Publique - Hôpitaux de Paris 180
Testing effectiveness (Phase 2)Study completedNCT02500550
What this trial is testing

Safety and Efficacy of Two Doses of ATIR101, a T-lymphocyte Enriched Leukocyte Preparation Depleted of Host Alloreactive T-cells, in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a Haploidentical Donor

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic Syndrome
Kiadis Pharma 15
Testing effectiveness (Phase 2)UnknownNCT03083574
What this trial is testing

Extracorporeal Photopheresis Using Theraflex ECP™ for Patients With Refractory Chronic Graft Versus Host Disease (cGVHD)

Who this might be right for
Refractory Chronic Graft Versus Host Disease (cGVHD)
Jules Bordet Institute 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06075225
What this trial is testing

MAP-guided Preemptive Therapy of aGvHD by Ruxolitinib

Who this might be right for
GVHDAcute Stem Cell Transplant Complications
Sichuan University 62
Not applicableNot Yet RecruitingNCT07235501
What this trial is testing

Kinetic Analysis of Immune Cells in Blood and Chronic Graft-Versus-Host Disease-Affected Tissues After Allogeneic Hematopoietic Cell Transplantation

Who this might be right for
Graft Versus Host DiseaseHematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm
City of Hope Medical Center 75
Early research (Phase 1)Study completedNCT00813618
What this trial is testing

Study of MEDI 507 in the Treatment of Pediatric Patients

Who this might be right for
Graft Versus Host Disease
MedImmune LLC 10
Testing effectiveness (Phase 2)Looking for participantsNCT02918188
What this trial is testing

Therapeutic Effects of Hydrogen on Steroid-refractory/or Steroid-dependent cGVHD

Who this might be right for
Chronic Graft-versus-host Disease
Navy General Hospital, Beijing 21
Not applicableStudy completedNCT02991846
What this trial is testing

A Prospective Observational Study for Evaluating CGVHD

Who this might be right for
Chronic Graft-Versus-Host Disease
Gruppo Italiano Trapianto di Midollo Osseo 248
Not applicableLooking for participantsNCT05866302
What this trial is testing

Parametric Response Mapping (PRM) for the Detection of Chronic Lung Injury in Hematopoietic Cell Transplant Recipients

Who this might be right for
Chronic Lung DiseaseHematopoietic Cell TransplantationGraft Versus Host Disease
University of Michigan Rogel Cancer Center 375
Testing effectiveness (Phase 2)Study completedNCT00388362
What this trial is testing

Sirolimus as Treatment of Steroid-Refractory or Steroid-Dependent Chronic Graft-Versus-Host Disease

Who this might be right for
Graft vs Host Disease
Stanford University 36
Testing effectiveness (Phase 2)Looking for participantsNCT06619561
What this trial is testing

Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)

Who this might be right for
Chronic Graft-Versus-Host Disease (cGVHD)
Deciphera Pharmaceuticals, LLC 48
Testing effectiveness (Phase 2)Ended earlyNCT00720629
What this trial is testing

Visilizumab for the Prevention of Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation

Who this might be right for
Graft Versus Host Disease
H. Lee Moffitt Cancer Center and Research Institute 8
Testing effectiveness (Phase 2)Study completedNCT01349101
What this trial is testing

A Research Study of Bone Marrow Transplantation From Unrelated or Partially Matched Related Donors

Who this might be right for
Hematological Malignancies
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 78
Testing effectiveness (Phase 2)Study completedNCT00284986
What this trial is testing

Safety and Efficacy of Prochymal for the Salvage of Treatment-Refractory Acute GVHD Participants

Who this might be right for
Graft Versus Host Disease
Mesoblast, Inc. 11
Not applicableWithdrawnNCT01569373
What this trial is testing

Analysis of Biomarkers for Acute Graft-versus-Host Disease (GVHD)

Who this might be right for
Blood Stem Cell Transplant Failure
Mayo Clinic
Very early researchEnded earlyNCT03546556
What this trial is testing

18-FLT PET/MR Imaging to Predict Graft Failure and GVHD in Bone Marrow Transplant Patients

Who this might be right for
Graft Vs Host Disease
UNC Lineberger Comprehensive Cancer Center 10
Testing effectiveness (Phase 2)Looking for participantsNCT06626737
What this trial is testing

Dapagliflozin in Allo-HCT for aGVHD

Who this might be right for
Graft-versus-host Disease (GVHD)
The First Affiliated Hospital of Soochow University 72
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07162688
What this trial is testing

Effects of Omega-3 Fatty Acids on Acute Graft-versus-Host Disease After Allogeneic Stem Cell Transplantation.

Who this might be right for
Graft-Versus-Host Disease(GVHD)
Fujian Medical University 30
Testing effectiveness (Phase 2)Study completedNCT02195869
What this trial is testing

Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Chronic Graft Versus Host Disease

Who this might be right for
Graft Versus Host Disease
Pharmacyclics LLC. 45
Testing effectiveness (Phase 2)Study completedNCT02027805
What this trial is testing

Safety and Efficacy Study of T-Guard to Treat Steroid-resistant Acute GVHD

Who this might be right for
Graft vs Host Disease
Xenikos 20
Load More Results